The Fly | PACB

High Accuracy Long Reads (HiFi): SMRT Sequencing delivers highly accurate long reads (HiFi reads) that combine the benefits of both short and long-read technologies, enabling comprehensive variant detection and resolving complex genomic regions with high fidelity.

Comprehensive Variant Detection: PacBio's technology excels at detecting all types of genetic variation, including single nucleotide variants, indels, and structural variants, particularly in challenging regions of the genome where short-read methods often fall short.

Direct Epigenetic Insights: SMRT Sequencing inherently detects DNA methylation patterns without requiring additional sample preparation steps, providing valuable epigenetic information directly from the sequencing data.

Intense Competition from Rivals: The market for DNA sequencing technologies is highly competitive, with established players like Illumina and emerging rivals such as Oxford Nanopore offering competing or complementary platforms that could limit PACB's market share and pricing power.

Slow Market Adoption of Long-Read Technology: Despite its unique advantages, the broader adoption of PacBio's long-read sequencing technology, particularly in large-scale clinical diagnostics, may be slower than anticipated due to cost, throughput, or data analysis complexities, impacting revenue growth.

Dependence on Successful Research & Development: Pacific Biosciences' future growth relies heavily on its ability to continuously innovate and successfully develop and commercialize new products, improved chemistries, and higher-throughput instruments, and failure to do so could result in a loss of competitive edge.